Wheat Ridge, COLORADO3 Active Studies

Ankylosing Spondylitis Clinical Trials in Wheat Ridge, COLORADO

Find 3 actively recruiting ankylosing spondylitis clinical trials in Wheat Ridge, COLORADO. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,196
Enrolling

Recruiting Ankylosing Spondylitis Studies in Wheat Ridge

About Ankylosing Spondylitis Clinical Trials in Wheat Ridge

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 3 ankylosing spondylitis clinical trials recruiting participants in Wheat Ridge, COLORADO. These studies are seeking a combined 1,196 participants. Research is being sponsored by Sanofi, Bristol-Myers Squibb, GlaxoSmithKline. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Wheat Ridge — FAQ

Are there ankylosing spondylitis clinical trials in Wheat Ridge?

Yes, there are 3 ankylosing spondylitis clinical trials currently recruiting in Wheat Ridge, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Wheat Ridge?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wheat Ridge research site will contact you about next steps.

Are clinical trials in Wheat Ridge free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wheat Ridge studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 3 active trials in Wheat Ridge are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov